Calls Purchased on Acorda Therapeutics, Inc.

Shares of Acorda Therapeutics, Inc. ACOR are higher on the session by 2.01%, currently trading at $32.00. The stock has been moving largely higher over the past three months and is currently trading above the 200-day moving average. Options traders are buying calls on the name today. Though action has been primarily in small lots, overall call volume is now running at 2.06x the daily average with 98% of all calls traded being purchases on the offer. Acorda Therapeutics, Inc. is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI) and other disorders of the nervous system.